Article

Keith Dunleavy, MD, Speaks About Health and Data Research

Keith Dunleavy, MD, President and CEO, Inovalon, discusses the importance of comparative effectiveness research in order to improve chronic disease management at both the individual and population levels.

Keith Dunleavy, MD, President and CEO, Inovalon, discusses the importance of comparative effectiveness research in order to improve chronic disease management at both the individual and population levels. Dr. Dunleavy also addresses decision support through target interventions.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Hans Lee
Dr Caroline Vovan
Dr María Díez Campelo
Dr Hans Lee
Dr María Díez Campelo
Nicole Bajic, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo